Abstract:[1]Schmidt WM,Sedivy R,Forstner B, et al. Progressive up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence[J]. Mol Carcinog, 2007,46(9): 766-772.
[2]陆嵘,房静远.重组DNA甲基化酶1表达质粒对结肠癌细胞相关基因表达的影响[J].中国消化杂志, 2004,24(2):67-70.
[3]Hermann A, Gowher H, Jeltsch A. Biochemistry and biology of mammalian DNA methyltransferases[J]. Cell Mol Life Sci, 2004, 61(19-20): 2571-2587.
[4]Robert MF, Morin S, Beaulieu N, et al. DNMT1 is required to maintain CpG;methylation and aberrant gene silencing in human cancer cells[J]. Nat Genet, 2003, 33(1): 61-65.
[5]Suzuki M, Sunaga N, Shames DS, et al. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells[J]. Cancer Res, 2004, 64(9): 3137-3143.
[6]Karpf AR, Matsui S. Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells[J]. Cancer Res, 2005, 65(19): 8635-8639.
[7]Zhu YM, Huang Q, Lin J, et al. Expression of human DNA methyltransferase 1 in colorectal cancer tissues and their corresponding distant normal tissues[J]. Int J Colorectal Dis, 2007, 22(6): 661-666.
[8]Etoh T, Kanai Y, Ushijima S, et al. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers[J]. Am J Pathol,2004,164(2): 689-699.
[9]翟荣林, 蔡开琳, 王国斌. Dnmt1, Dnmt3a, Dnmt3b和HMT在不同结肠癌细胞系的表达及意义[J].世界华人消化杂志, 2008,16(4): 426-430.
[10]彭过,戴冬秋. 消化道肿瘤组蛋白乙酰化与甲基化的研究进展[J].中华肿瘤防治杂志,2007,14(24):1914-1915.
[11]Maria F. Paz, Susan Wei. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells decient in DNA methyltransferases[J]. Human Molecular Genetics, 2003, 12(17): 2209–2219.
[12]王汉姣,吴建兵.甲基化CpG结合蛋白在肿瘤表遗传学研究中的进展[J].实用临床医学,2007,8(7):126-128.
[13]Fang JY, Chen YX, Lu J, et al. Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines:Colo-320 and SW1116[J].Cell Research,2004,14(3):217-226.
[14]Suzuki H, Gabrielson E, Chen W, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase Inhibition in human colorectal cancer[J].Nat Genet,2002,31(2):141-149.
[15]Sharrard RM, Royds JA, Rogers S, et al. Patterns of methylation of the c-myc gene in human colorectal cancer progression[J]. Br J Cance,1992,65(5):667-672.
[16]罗伟仁,陈小毅.环氧化酶-2与肿瘤的关系[J].肿瘤防治研究,2006,33(1):62-64.
[17]Li HW, Li YH. The expressions of Cox-2 and surviving in 80 cases of colonal carcinoma and their clinical significance[J]. Modern Oncology, 2008,16(4):597-599.
[18]Toyota M, Shen L, OheToyota M, et al. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors[J]. Cancer Res, 2000, 60(15):4044-4048.
[19]Zdenko, Herceg. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors[J]. Mutagenesis, 2007,22(2): 91-103.
[20]Van Engeland M,Roemen GM,Brink M,et al.K-ras mutations and RASSFIA promoter methylation in colorectal cancer[J]. Oncogene, 2002,21(23):3792-3795
[21]Carneiro FP, Ramalho LN, Britto-Garcia S, et al. Immunohistochemical expression of p16,p53,and p63 in colorectal adenomas and adenocarcinomas[J]. Dis Colon Rectum,2006,49(5):588-594.
[22]程苏琴,曹佳.大肠癌中p16基因的甲基化改变与蛋白表达的关系[J]. China Lab Med,2004,27(5):307-310
[23]戴文斌.Wnt通路成员APC、β-catenin、c-myc及黏附分子E-cadherin与大肠癌的关系[J].中国肿瘤临床与康复,2007,14(1):73-76.
[24]张华,府伟灵,黄庆.散发性大肠癌中hMLH1基因启动子区CpG岛MVPs图谱的绘制与分析[J].第三军医大学学报,2007,29(20):1961-1963.